n-vinyl-2-pyrrolidinone has been researched along with Coronary Restenosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antunes, E; Krieger, MH; Lemos, ME; Marcondes, S; Shishido, SM; Sorragi, Cde L | 1 |
1 other study(ies) available for n-vinyl-2-pyrrolidinone and Coronary Restenosis
Article | Year |
---|---|
In vitro evaluation of the safe margin, antithrombotic and antiproliferative actions for the treatment of restenosis: Nitric oxide donor and polymers.
Topics: Animals; BALB 3T3 Cells; Cell Proliferation; Coronary Restenosis; Drug Evaluation, Preclinical; Drug-Eluting Stents; Drug-Related Side Effects and Adverse Reactions; Fibrinolytic Agents; Humans; Mice; Myocytes, Smooth Muscle; Nitric Oxide; Nitric Oxide Donors; Platelet Adhesiveness; Platelet Aggregation; Polyvinyl Alcohol; Povidone; Rabbits; S-Nitrosoglutathione | 2011 |